Inmune Bio (INMB) Return on Assets [ROA] (2019 - 2026)
Inmune Bio (INMB) posted Return on Assets [ROA] of -76.70% for Q2 2026, up 72.29 percentage points from -148.98% a year earlier and up 72.15 percentage points from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Return on Assets [ROA] (2019 - 2026) Analysis & Trends
For FY2025, Inmune Bio's Return on Assets [ROA] came in at -131.78%, down 43.47 percentage points from FY2024.
- Annual Return on Assets [ROA] has declined for three consecutive years, with a five-year change of -94.23 percentage points (FY2020 to FY2025).
- In prior years, Inmune Bio's Return on Assets [ROA] was -88.31% in FY2024 (-45.45 pp), -42.86% in FY2023 (-14.30 pp), -28.56% in FY2022 (+12.91 pp) and -41.47% in FY2021 (-3.92 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Assets [ROA] since Q2 2024.
- On a year-over-year basis, Return on Assets [ROA] increased in 1 of the last eight quarters, with an average year-over-year change of -35.21 percentage points.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2026, with a gain of 72.29 percentage points; the weakest was Q2 2025, with a drop of 72.86 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -148.84% (Q1 2026), -144.22% (Q4 2025) and -144.64% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Inmune Bio | 30.71 Mn | -50.14 Mn | - | -69.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -69.25% |
| Jun 30, 2026 | -70.17% |
| Mar 31, 2026 | -143.44% |
| Dec 31, 2025 | -140.30% |
| Sep 30, 2025 | -139.68% |
| Jun 30, 2025 | -147.20% |
| Mar 31, 2025 | -105.31% |
| Dec 31, 2024 | -90.66% |
| Sep 30, 2024 | -79.01% |
| Jun 30, 2024 | -76.03% |
| Mar 31, 2024 | -66.37% |
| Dec 31, 2023 | -50.31% |
| Sep 30, 2023 | -40.82% |
| Jun 30, 2023 | -37.03% |
| Mar 31, 2023 | -35.56% |
| Dec 31, 2022 | -33.88% |
| Sep 30, 2022 | -37.55% |
| Jun 30, 2022 | -36.86% |
| Mar 31, 2022 | -33.66% |
| Dec 31, 2021 | -29.24% |
API Access
Inmune Bio Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();